Tibballs, James
Tibballs, James
Dr Jim Tibballs, Deputy Director of Intensive Care at the Royal Children's Hospital in Melbourne, has been involved in venom research for many years. His research interests have included the cardiovascular effects of box jellyfish venom, brown snake procoagulants and most recently the clinical effects of the Irukandji syndrome. This research was presented at the 13th World Congress of the International Society on Toxinology in Paris, September 2000 (see Published Sources). He became an honorary senior associate of the Australian Venom Research Unit in 1997 and is now a Honorary Principal Fellow. In 1998, he completed his MD in toxinology, and he also has a masters degree in education. He is the co-author (with Professor Sutherland) of the 2001 edition of Australian Animal Toxins.
Pages in this category
Gallery
Publications
Jellyfish Antivenoms: Past, Present, and Future
.
2003. Jellyfish Antivenoms: Past, Present, and Future. Journal of Toxicology. 22(1):115-127.
The in Vivo Cardiovascular Effects of Irukandji (Carukia Barnesi) Venom
.
2000. The in Vivo Cardiovascular Effects of Irukandji (Carukia Barnesi) Venom. International Society on Toxinology 13th World Congress on Animal Plant and Microbial Toxins.
Sever Tiger Snake Envenomation in a Wilderness Environment
.
1998. Sever Tiger Snake Envenomation in a Wilderness Environment. The Medical Journal of Australia. 169(4):228-229.
Premedication For Snake Antivenom
.
1994. Premedication For Snake Antivenom. The Medical Journal of Australia. 160:4-7.
